Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Current Taxes (2016 - 2023)

Harvard Bioscience (HBIO) has disclosed Current Taxes for 14 consecutive years, with $398000.0 as the latest value for Q2 2023.

  • Quarterly Current Taxes rose 665.38% to $398000.0 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $398000.0 through Jun 2023, up 665.38% year-over-year, with the annual reading at $224000.0 for FY2021, 21.68% down from the prior year.
  • Current Taxes for Q2 2023 was $398000.0 at Harvard Bioscience, down from $700000.0 in the prior quarter.
  • The five-year high for Current Taxes was $1.3 million in Q1 2019, with the low at $52000.0 in Q2 2022.
  • Average Current Taxes over 5 years is $505250.0, with a median of $471000.0 recorded in 2021.
  • The sharpest move saw Current Taxes skyrocketed 3121.05% in 2019, then plummeted 90.44% in 2022.
  • Over 5 years, Current Taxes stood at $609000.0 in 2019, then plummeted by 53.04% to $286000.0 in 2020, then dropped by 21.68% to $224000.0 in 2021, then plummeted by 76.79% to $52000.0 in 2022, then skyrocketed by 665.38% to $398000.0 in 2023.
  • According to Business Quant data, Current Taxes over the past three periods came in at $398000.0, $700000.0, and $52000.0 for Q2 2023, Q1 2023, and Q2 2022 respectively.